Recognizing the multimodality imaging features of the biliary system and liver parenchyma in primary sclerosing cholangitis can help the radiologist provide an accurate diagnosis, identify a differ... Primary sclerosing cholangitis (PSC) is a chronic progressive inflammatory disease of the bile ducts that leads to multifocal bile duct fibrosis, strictures, cholestasis, liver parenchymal changes,...

Aim: To determine whether socioeconomic status (SES; educational attainment and income) explains the racial gap in cancer beliefs, cognitions, and emotions in a national sample of American adults. Methods: For this cross-sectional study, data came from the Health Information National Trends Survey (HINTS) 2017, which included a nationally representative sample of American adults. The study enrolled 2277 adults who were either non-Hispanic Black (n = 409) or non-Hispanic White (n = 1868). Race, demographic factors (age and gender), SES (i.e., educational attainment and income), health access (insurance status, usual source of care), family history of cancer, fatalistic cancer beliefs, perceived risk of cancer, and cancer worries were measured. We ran structural equation models (SEMs) for data analysis. Results: Race and SES were associated with perceived risk of cancer, cancer worries, and fatalistic cancer beliefs, suggesting that non-Hispanic Blacks, low educational attainment and low income were associated with higher fatalistic cancer beliefs, lower perceived risk of cancer, and less cancer worries. Educational attainment and income only partially mediated the effects of race on cancer beliefs, emotions, and cognitions. Race was directly associated with fatalistic cancer beliefs, perceived risk of cancer, and cancer worries, net of SES. Conclusions: Racial gap in SES is not the only reason behind racial gap in cancer beliefs, cognitions, and emotions. Racial gap in cancer related beliefs, emotions, and cognitions is the result of race and SES rather than race or SES. Elimination of racial gap in socioeconomic status will not be enough for elimination of racial disparities in cancer beliefs, cognitions, and emotions in the United States.

Pancreatic cystic neoplasms 15–25 mm in size were most likely to show growth on follow-up images obtained with CT or MRI; however, very small lesions (<5 mm) showed no interval growth until at leas... Background Incidental detection of pancreatic cystic neoplasm (PCN) has increased. Since a small percentage of PCNs possess malignant potential, management is challenging. The recently revised Amer...

Objective: As age is one of the main risk factors for lung cancer, older adults are expected to receive more messages regarding lung cancer screening (LCS). It is, however, unclear whether age similarly increases patients’ chance of discussing LCS across various racial groups. We aimed to determine racial differences in the effect of patients’ age on patient‐physician discussion about LCS.Methods: This cross‐sectional study borrowed data from the Health Information National Trends Survey 5 (HINTS 2017), which included 2277 adults. Patients’ demographic factors, socioeconomic characteristics, smoking status, possible LCS indication, and patient‐physician discussion about LCS were measured. We ran logistic regression models for data analysis.Results: Independent of possible LCS indication, older patients were more likely to have a patient‐physician discussion about LCS. However, there was a significant interaction between race and age, suggesting a larger effect of age on the likelihood of discussing LCS with doctors for Whites than Blacks. In race‐stratified models that controlled for possible LCS indication, higher age increased lung cancer discussion for Whites but not for Blacks.Conclusion: Whether age increases the chance of discussing LCS or not depends on the patient's race, with Blacks receiving fewer messages regarding LCS as a result of their aging.

Baseline multiparametric MRI assessment including volumetric apparent diffusion coefficient, percentage viable tumor volume, and viable tumor burden can help predict mortality risk in patients with unresectable intrahepatic cholangiocarcinoma undergoing transcatheter arterial chemoembolization. PurposeTo evaluate whether baseline MRI can help predict survival in patients with unresectable intrahepatic cholangiocarcinoma (ICCA) undergoing transcatheter arterial chemoembolization (TACE).Materials and MethodsThis retrospective study was compliant with HIPAA and approved by the institutional review board. The requirement to obtain informed consent was waived. The study included 111 patients (mean age, 62 years ± 12; range, 29–86 years), with 44 men (mean age, 61 years ± 12; range, 29–81 years) and 67 women (mean age, 63 years ± 12; range, 34–86 years). Patients underwent TACE after baseline MRI, which included contrast-enhanced and diffusion-weighted imaging with apparent diffusion coefficient (ADC) mapping between 2003 and 2016. The single largest tumor was assessed independently by a radiologist for anatomic and functional (viable tumor volume, percentage viable tumor volume [100 × viable tumor volume/whole tumor volume], viable tumor burden [100 × viable tumor volume/whole liver volume], and ADC)...